Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.680
-0.570 (-13.41%)
At close: May 11, 2026, 4:00 PM EDT
3.940
+0.260 (7.07%)
After-hours: May 11, 2026, 7:47 PM EDT
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $2.39 million as of May 11, 2026. Its market cap has decreased by -40.30% in one year.
Market Cap
2.39M
Enterprise Value
-9.02M
1-Year Change
-40.30%
Ranking
Category
Stock Price
$3.68
Market Cap Chart
Since February 26, 2019, Biodexa Pharmaceuticals's market cap has decreased from $102.08M to $2.39M, a decrease of -97.66%. That is a compound annual growth rate of -40.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 2.76M | 44.71% |
| Dec 31, 2025 | 1.90M | -19.05% |
| Dec 31, 2024 | 2.35M | -66.48% |
| Dec 29, 2023 | 7.02M | 78.13% |
| Dec 30, 2022 | 3.94M | -68.73% |
| Dec 31, 2021 | 12.60M | -43.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Calidi Biotherapeutics | 3.05M |
| Virax Biolabs Group | 2.97M |
| Decoy Therapeutics | 2.89M |
| Soligenix | 2.89M |
| AIM ImmunoTech | 2.51M |
| Oragenics | 2.42M |
| Bone Biologics | 2.30M |
| Artelo Biosciences | 2.27M |